| Description | HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1]. |
| In vivo | HBV-IN-41（化合物45）（20 mg/kg，口服，BID，连续7天）在HBV AAV小鼠模型中通过口服途径显著降低了HBV DNA水平[1]。 |
| molecular weight | 407.83 |
| Molecular formula | C18H19ClFN5O3 |
| CAS | 1967002-25-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |